But he knows that it isn't in fact definitive
, so he "asks" everyone to "reverently receive this teaching as definitive
In addition to launching the campaign in retail, Definitive
Technology is engaging Facebook fans for a chance to win an all-expenses paid trip to see John Legend perform in January in Las Vegas.
The Company anticipates signing a definitive
agreement relating to its business combination with the Target within the next 30 days.
For example, the unsolicited non-binding proposal from the Third Party Group may not result in a definitive
agreement for an alternative transaction.
Additional information regarding the interests of such potential participants will be included in the definitive
proxy statement and the other relevant documents filed with the SEC when they become available.
Under the terms of the May 2006 Agreement, the parties agreed to enter into definitive
transactional documents if Beijing Med-Pharm emerged as the winning bidder for Rongheng on the Shanghai Exchange.
In order to vote their shares in favor of the Harbinger Capital Partners agreement, shareholders should complete, date, sign and return the proxy card enclosed with the previously distributed definitive
proxy statement as soon as possible.
Investors and security holders are advised to read the registration statement containing a definitive
proxy statement/prospectus that will be mailed to all stockholders of record because it contains important information.
NASDAQ:CELL) and CellStar Corporation (Pink Sheets:CLST) announced today that they have entered into a definitive
Agreement") for a wholly-owned subsidiary of Brightpoint, Inc.
ICOS intends to file a revised definitive
proxy statement and other documents regarding the proposed acquisition of ICOS by Lilly with the Securities and Exchange Commission (the "SEC").
There are a number of important factors that could cause actual results to differ materially from those projected, including risks associated with our ability to satisfy the conditions to closing set forth in the definitive
agreement, product commercialization, research and clinical development, regulatory approvals, manufacturing, collaboration arrangements, liquidity, competition, intellectual property claims, litigation and other risks detailed in our latest Quarterly Report on Form 10-Q and our other public filings with the Securities and Exchange Commission.
Stockholders are urged to read the Company's amended preliminary proxy statement and, when available, the Company's definitive
proxy statement in connection with the Company's proposed business combination because these proxy statements will contain important information concerning Summer Infant and the Company's proposed business combination.